“Psilocybin for Major Depressive Disorder”
Produced by:
JN Learning Podcast
In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, speaks with author Charles L. Raison, MD, from Vail Health Behavioral Health, about the study, as well as Rachel Yehuda, PhD, Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies.
Listen Now >
“Treating the Depressed Brain”
Produced by:
Chasing Life with Dr. Sanjay Gupta
Nearly one in five US adults are diagnosed with depression at some point in their lives. As the use of antidepressants have steadily risen since their introduction in the 1980s, what have we learned about depression? Is depression truly a “chemical imbalance” of the brain? And why do antidepressants work for some people and not others? Sanjay talks to Dr. Charles Raison, a professor of psychiatry at the University of Wisconsin-Madison and Director of Vail Health Behavioral Health Innovation Center, about what we now believe causes depression, and most importantly, what this means for how we treat the illness - from SSRIs to psychedelics and other emerging therapies.
Listen Now >